NASDAQ · Biotechnology

ABSI (ABSI) Stock

$7.13 -5.69% NASDAQ: ABSI Healthcare

Valuation

MetricValue
Price$7.13
Market Cap$1.21B
P/E Ratio-11.32
P/B Ratio6.59
P/S Ratio619.46
EPS (TTM)$-0.63
52-Week High$11.90
52-Week Low$2.24
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-63.89%
ROA-37.33%
ROCE-66.14%
Gross Margin-13.17%
Operating Margin-70.01%
Net Margin-64.51%
Debt/Equity0.03
Current Ratio6.52

Annual Financials (USD)

Metric20212022202320242025
Revenue$5.0M$6.0M$6.0M$5.0M$3.0M
Operating Profit$-75.0M$-107.0M$-116.0M$-109.0M$-125.0M
Net Profit$-101.0M$-105.0M$-111.0M$-103.0M$-115.0M
EPS$-1.11$-1.15$-1.20$-0.94$-0.84
Op Margin-1573.4%-1857.5%-2020.2%-2401.6%-4454.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$426.0M$321.0M$217.0M$214.0M$216.0M
Total Liabilities$60.0M$47.0M$41.0M$34.0M$27.0M
Cash$253.0M$60.0M$72.0M$41.0M$20.0M
Borrowings$20.0M$23.0M$16.0M$10.0M$5.0M

Latest News

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 CNW Group · Jul 15, 2026 Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 GlobeNewswire · Jul 14, 2026 Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know Zacks · Jul 13, 2026 Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy Zacks · Jul 2, 2026 Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program Benzinga · Jun 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-61.0M$-81.0M$-65.0M$-72.0M$-93.0M
Investing Cash Flow$-105.0M$-143.0M$81.0M$-42.0M$-51.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$208.0M$-203.0M$13.0M$-31.0M$-37.0M
Free Cash Flow$-99.0M$-98.0M$-65.0M$-73.0M$-94.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-8.06
FCF Yield-8.66%
Quick Ratio6.59
Interest Coverage—
Return 1Y129.26%
Return 3Y252.40%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRVS $13.31 +3.02% -23.00 $1.12B 0.00%
ERAS $17.72 -2.42% -23.45 $6.15B 0.00%
GOSSGossamer Bio, Inc. $0.19 +38.24% -0.17 $44.10M 0.00%
MGTXMeiraGTx Holdings plc $12.31 +0.04% -7.95 $1.14B 0.00%
MLTX $19.57 -1.58% -4.71 $1.62B 0.00%

About ABSI

ABSI is led by CEO Sean McClain, employs 156 people, headquartered in US, publicly traded since 2021.

ABSI stock trades at $7.13 with a market capitalization of $1.21B. The stock is valued at a price-to-earnings (P/E) ratio of -11.32, price-to-book of 6.59, price-to-sales of 619.46. Over the past 52 weeks the stock has ranged between $2.24 and $11.90, and currently trades 40.1% below its 52-week high.

On profitability, ABSI generates a return on equity (ROE) of -63.89%, return on capital employed of -66.14%, an operating margin of -70.01%, a net profit margin of -64.51%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides